Insulet Corporation (PODD) News
Filter PODD News Items
PODD News Results
|Event/Time||Symbol||Company||News Detail||Start||End||Change||POWR Rating|
|Loading, please wait...|
Latest PODD News From Around the Web
Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.
Wearable Injectors Market 2020 Research and New Innovations in Medical Sector- Amgen, Becton, Dickinson and Company, Dexcom, Insulet Corporation
Oct 02, 2020 (Market Insight Reports) -- This Global Wearable Injectors Market Research Report Forecast 2020-2025 is a valuable source of insightful data for…
Insulin Pumps Market Overview and Scope 2020 to 2027 | Key Players - Animus Corporation, Asante, Insulet Corporation, Nipro Diagnostic Inc
Global Insulin Pumps Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share, and size. The Global Insulin Pumps Market research report provides a rational explanation to the reader to understand
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Annexon Inc (NASDAQ: ANNX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) CTI BioPharma Corp (NASDAQ: CTIC ) I-Mab ADR (NASDAQ: IMAB ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) (the blank check company announced a business combination with oncology-focused Vincera Pharma) Mirati Th...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc (NASDAQ: XLRN ) (announced Health Canada approval of luspatercept for RBC transfusion-dependent anemia associated with beta-thalassemia) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Adial Pharmaceuticals Inc (NASDAQ: ADIL )(announced EUA for antibody test for COVID-19) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Fate Therapeutics Inc (NASDAQ: FA...
Insulet (PODD) announces that it has launched its Omnipod DASH System in Sweden, Finland, Norway and Denmark, and will add France, Belgium, Germany, Austria, Switzerland and Israel in the coming weeks.It previously launched the device, which provides up to three days on continuous insulin delivery, in the U.S., UK, the...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two virtual investor conferences: The Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020, at 12:15 p.m. (Eastern Time) The Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020, at 9:45 a.m. (Eastern Time) To listen to liv
Insulet Corporation (PODD) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Deborah Gordon – Vice President-Investor Relations Shacey Petrovic – President and Chief Executive Officer Wayde McMillan – Executive Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen – Wells Fargo Robbie Marcus...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended June 30, 2020. Second Quarter Financial Highlights: Second quarter 2020 revenue of $226.3 million, up 27.8%, or 28.8% in constant currency1, compared to $177.1 million in the prior year, exceeds guidance of 19% to 23% on a constan
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]